Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives

Laleh Amiri-Kordestani, Julia Beaver, Patricia Cortazar

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalOncology (Williston Park, N.Y.)
Volume29
Issue number11
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Neoadjuvant Therapy
Publications
Delivery of Health Care
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Neoadjuvant Therapy As a Platform for Drug Development : Current Controversies and Regulatory Perspectives. / Amiri-Kordestani, Laleh; Beaver, Julia; Cortazar, Patricia.

In: Oncology (Williston Park, N.Y.), Vol. 29, No. 11, 01.11.2015.

Research output: Contribution to journalArticle

@article{5a5091c9a5944f91ad18f66b00fc0abd,
title = "Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives",
author = "Laleh Amiri-Kordestani and Julia Beaver and Patricia Cortazar",
year = "2015",
month = "11",
day = "1",
language = "English (US)",
volume = "29",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "11",

}

TY - JOUR

T1 - Neoadjuvant Therapy As a Platform for Drug Development

T2 - Current Controversies and Regulatory Perspectives

AU - Amiri-Kordestani, Laleh

AU - Beaver, Julia

AU - Cortazar, Patricia

PY - 2015/11/1

Y1 - 2015/11/1

UR - http://www.scopus.com/inward/record.url?scp=85047584715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047584715&partnerID=8YFLogxK

M3 - Article

C2 - 26573064

AN - SCOPUS:84947247013

VL - 29

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 11

ER -